A U.S. pharmaceutical company is attempting to build out a full clinical trial for a drug that could potentially prevent COVID-19 infections - among other viral ailments - in long-term care settings. The Tampa, Fla.-based Romark Laboratories has high hopes for its NT-300 drug, an existing oral medication that works by preventing a virus from [...] The post Drugmaker Romark Seeks Nursing Home Residents for COVID-19 Clinical Trial appeared first on Skilled Nursing News.